Targeted pathway-based in vivo testing using thyroperoxidase inhibition to evaluate plasma thyroxine as a surrogate metric of metamorphic success in model amphibian Xenopus laevis
Description
These data are represented in tables and graphs in the article, "Targeted pathway-based in vivo testing using thyroperoxidase inhibition to evaluate plasma thyroxine as a surrogate metric of metamorphic success in model amphibian Xenopus laevis" by JT Haselman et al.
This dataset is associated with the following publication:
Haselman, J., J. Olker, P. Kosian, J. Korte, J. Swintek, J. Denny, J. Nichols, J. Tietge, M. Hornung, and S. Degitz. Targeted pathway-based in vivo testing using thyroperoxidase inhibition to evaluate plasma thyroxine as a surrogate metric of metamorphic success in model amphibian Xenopus laevis. TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA, 175(2): 236-250, (2020).
Resources
| Name |
Format |
Description |
Link |
|
53 |
Haselman_et_al_2019_data_SciHub.xlsx |
https://pasteur.epa.gov/uploads/10.23719/1504195/Haselman_et_al_2019_data_SciHub.xlsx |
Tags
- thyroperoxidase
- xenopus-laevis
- adverse-outcome-pathway
- thyroid